Obesity & Weight Management

Since Novo Nordisk was founded more than 90 years ago, we have been driving change to defeat diabetes.  Novo Nordisk is using its knowledge of protein chemistry, understanding of hormones and disease insight to develop treatments for people with obesity.

Obesity can have many serious health consequences, including type 2 diabetes, heart disease, high blood pressure, obstructive sleep apnoea and many types of cancer.

Novo Nordisk are committed to addressing the significant unmet medical needs in obesity care and our ambition is to drive scientific progress in this disease area and develop treatment options for obesity.
 

  • Healthy eating and physical activity must
    be part of any weight loss intervention, but
    this is not always sufficient to maintain
    weight loss.  The body is pre-programmed
    to fight weight loss as a natural defence in
    a famine-like situaiton.  So when someone
    eats less, their metabolism will slow down
    and the brain will subconsciously increase
    hunger signals.
  • To help people achieve meaningful and
    sustainable weight loss, Novo Nordisk is
    focusing on developing treatments.  Our
    aim is to reduce the risks of certain
    comorbidiites associated with obesity,
    and thereby improve the health and
    quality of life of people living with obesity.

Updated: March 2018